Salonpas® Named the World's No. 1 OTC Topical Analgesic Patch Brand*1 for the Third Consecutive Year

May 17, 2019 - 07:32
Salonpas® Named the World's No. 1 OTC Topical Analgesic Patch Brand*1 for the Third Consecutive Year

Based on research by Euromonitor International (UK),*2 a leading global market research company

 

TOKYO,JAPAN - Media OutReach - 17 May 2019 - Hisamitsu Pharmaceutical Co., Inc. (HeadOffice: Tosu, Saga; President & COO: NAKATOMI Kazuhide; hereinafter"Hisamitsu Pharmaceutical") announced that Euromonitor International Ltd.(hereinafter "Euromonitor International"), a leading international marketresearch company, recognized "Salonpas®" as the world's No. 1 OTCtopical analgesic patch brand for the third consecutive year since 2016.Euromonitor International presented Hisamitsu Pharmaceutical with two officialcertificates, one recognizing Salonpas®'s achievement and one namingHisamitsu Pharmaceutical as the holder of the world's largest share in thecorresponding market category for two years running.


Since its 1847 founding in the Tashiro (thenHizen-Tashiro) area of Tosu, Saga, Hisamitsu Pharmaceutical has worked to provideJapan and the rest of the world with high-quality pharmaceutical products. Alwaysfooting its operations in that local foundation and adhering to a consistent, customer-firstphilosophy, Hisamitsu Pharmaceutical is now in its 172nd year--a testament to a legacythat, like the recent recognition from Euromonitor International, would nothave been possible without the valuable, ongoing support of the company's many customersand stakeholders.


May 18 has been registered with the JapanAnniversary Association as "Salonpas® Day," whose date haslinguistic ties to the Japanese phrase "Korio iyasu" ("relieving stiffness"): "Ko"corresponds to the number 5 ("go"); "i" represents 1; and "ya" stands for 8.


Hisamitsu Pharmaceutical will continue toexpand its business operations worldwide, centering its activities on the basicprinciple of "Delivering a Better QOL to the World."

 

Certificatepresentation

Date: May17, 2019

Location: Hisamitsu Pharmaceutical Tokyo HeadOffice

L: Mr. Sean Kreidler, SeniorResearch Manager, Euromonitor International

R: NAKATOMI Kazuhide,President & COO, Hisamitsu Pharmaceutical




*1: Research Method

To determine theworld's No. 1 OTC topical analgesic patch brand, London-based EuromonitorInternational conducts a global market research from March to April every year.In the ten countries collectively representing more than 70% of the globaltopical patch product retail market in 2018 (the United States, Brazil, Russia,Italy, Germany, India, Indonesia, Vietnam, China, and Japan), EuromonitorInternational conducted trade interviews of manufacturers and wholesalers,visited retail outlets for store checks, and compiled the sales figures ofpatch products by country and brand to calculate the corresponding salesshares.

 

*2: EuromonitorInternational

Euromonitor International,a British company headquartered in London, is a leader in international marketresearch with exclusive researchers in over 100 countries.

E-paper